Basilea Pharmaceutica International Ltd.

Suisse

 
Quantité totale PI 3
Rang # Quantité totale PI 507 061
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 669 956
Parent Basilea Pharmaceutica AG

Brevets

Marques

2 0
0 0
1 0
0
 
Dernier brevet 2016 - Formulation for retinoid-contain...
Premier brevet 1999 - Azoles for treatment of fungal i...

Derniers inventions, produits et services

2016 Invention Formulation for retinoid-containing soft gelatin capsules. A new pharmaceutical formulation for ...
2015 Invention Oxidation process for preparing 3-formyl-cephem derivatives. The present invention relates to an ...
2006 Invention N-substituted carbamoyloxyalkyl-azolium derivatives. N-substituted carbamoyloxyalkyl-azolium deri...
Invention Treatment of cell-mediated immune diseases. 9-cis retinoic acid and pharmaceutically acceptable s...
2004 Invention N-phenyl substituted carbamoyloxyalkyl-azolium derivatives. N-substituted carbamoyloxyalkyl-azoli...
Invention Intermediates for n-substituted carbamoyloxyalkyl-azolium derivatives. N-substituted carbamoyloxy...
Invention Process for the production of 9-(z)-retinoic acid. 15-triphenyl-phosphonium salt. 9-(Z)-retinoic ...
2000 Invention Treatment of cell-mediated immune diseases. The invention is related to a method of treating chro...
1999 Invention Azoles for treatment of fungal infections. X.sup.- is a pharmaceutically acceptable anion; T is ...